1. Home
  2. XMTR vs LGND Comparison

XMTR vs LGND Comparison

Compare XMTR & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xometry Inc.

XMTR

Xometry Inc.

HOLD

Current Price

$92.59

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$271.90

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XMTR
LGND
Founded
2013
1987
Country
United States
United States
Employees
N/A
68
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
XMTR
LGND
Price
$92.59
$271.90
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$58.60
$256.29
AVG Volume (30 Days)
778.3K
175.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.95
N/A
EPS
N/A
N/A
Revenue
$686,631,000.00
N/A
Revenue This Year
$23.76
$1.25
Revenue Next Year
$18.38
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
25.87
N/A
52 Week Low
$30.63
$111.72
52 Week High
$99.86
$267.27

Technical Indicators

Market Signals
Indicator
XMTR
LGND
Relative Strength Index (RSI) 66.55 79.93
Support Level $56.76 $199.97
Resistance Level $99.86 N/A
Average True Range (ATR) 4.54 7.64
MACD -0.68 2.94
Stochastic Oscillator 70.88 99.67

Price Performance

Historical Comparison
XMTR
LGND

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: